These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 35316844)
1. Treatment of Metastatic Melanoma in the Elderly. Seedor RS; Orloff M Curr Oncol Rep; 2022 Jul; 24(7):825-833. PubMed ID: 35316844 [TBL] [Abstract][Full Text] [Related]
2. Engineered oncolytic viruses to treat melanoma: where are we now and what comes next? Rothermel LD; Zager JS Expert Opin Biol Ther; 2018 Dec; 18(12):1199-1207. PubMed ID: 30392405 [TBL] [Abstract][Full Text] [Related]
10. Combining Tumor Vaccination and Oncolytic Viral Approaches with Checkpoint Inhibitors: Rationale, Pre-Clinical Experience, and Current Clinical Trials in Malignant Melanoma. Cavalcante L; Chowdhary A; Sosman JA; Chandra S Am J Clin Dermatol; 2018 Oct; 19(5):657-670. PubMed ID: 29961183 [TBL] [Abstract][Full Text] [Related]
11. Oncolytic Newcastle disease virus expressing a checkpoint inhibitor as a radioenhancing agent for murine melanoma. Vijayakumar G; Palese P; Goff PH EBioMedicine; 2019 Nov; 49():96-105. PubMed ID: 31676387 [TBL] [Abstract][Full Text] [Related]
12. Checkpoint Blockade Plus Oncolytic Virus: A Hot Therapeutic Cancer Strategy. Robert C Trends Mol Med; 2017 Nov; 23(11):983-985. PubMed ID: 29137714 [TBL] [Abstract][Full Text] [Related]
13. The use of oncolytic virotherapy in the neoadjuvant setting. Thomas RJ; Bartee E J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35414592 [TBL] [Abstract][Full Text] [Related]
14. Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines. Vijayakumar G; McCroskery S; Palese P J Virol; 2020 Jan; 94(3):. PubMed ID: 31694938 [TBL] [Abstract][Full Text] [Related]
15. The safety of talimogene laherparepvec for the treatment of advanced melanoma. Gangi A; Zager JS Expert Opin Drug Saf; 2017 Feb; 16(2):265-269. PubMed ID: 27989216 [TBL] [Abstract][Full Text] [Related]
16. Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma. Bommareddy PK; Patel A; Hossain S; Kaufman HL Am J Clin Dermatol; 2017 Feb; 18(1):1-15. PubMed ID: 27988837 [TBL] [Abstract][Full Text] [Related]
17. Oncolytic Viruses for the Treatment of Metastatic Melanoma. Trager MH; Geskin LJ; Saenger YM Curr Treat Options Oncol; 2020 Mar; 21(4):26. PubMed ID: 32266483 [TBL] [Abstract][Full Text] [Related]